These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18997484)

  • 21. [Clinical analysis between trefoil factor 3 gene polymorphsims and susceptibility to papillary thyroid carcinoma].
    Pei D; Xue G; Wu JF; Wang DM; Qin XJ
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Oct; 33(10):926-931. PubMed ID: 31623036
    [No Abstract]   [Full Text] [Related]  

  • 22. Polymorphisms at the IL17A and IL17RA Genes are Associated with Prognosis of Papillary Thyroid Carcinoma.
    Bertol BC; Góes de Araújo JN; de Carvalho KTC; Gonzaga Dos Santos M; Martelli-Palomino G; de Figueiredo Feitosa NL; Maciel LMZ; Silbiger VN; Lucena-Silva N; Freitas JCOC; Donadi EA
    Arch Med Res; 2022 Feb; 53(2):163-169. PubMed ID: 34384609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of PTPRJ genotype in papillary thyroid carcinoma risk.
    Iuliano R; Palmieri D; He H; Iervolino A; Borbone E; Pallante P; Cianflone A; Nagy R; Alder H; Calin GA; Trapasso F; Giordano C; Croce CM; de la Chapelle A; Fusco A
    Endocr Relat Cancer; 2010 Dec; 17(4):1001-6. PubMed ID: 20823296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1513A>C polymorphism in the P2X7 receptor gene in patients with papillary thyroid cancer: correlation with histological variants and clinical parameters.
    Dardano A; Falzoni S; Caraccio N; Polini A; Tognini S; Solini A; Berti P; Di Virgilio F; Monzani F
    J Clin Endocrinol Metab; 2009 Feb; 94(2):695-8. PubMed ID: 19017759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer.
    Shih CM; Lee YL; Chiou HL; Hsu WF; Chen WE; Chou MC; Lin LY
    Lung Cancer; 2005 Dec; 50(3):291-7. PubMed ID: 16122836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of FOXE1 polyalanine repeat region with papillary thyroid cancer.
    Bullock M; Duncan EL; O'Neill C; Tacon L; Sywak M; Sidhu S; Delbridge L; Learoyd D; Robinson BG; Ludgate M; Clifton-Bligh RJ
    J Clin Endocrinol Metab; 2012 Sep; 97(9):E1814-9. PubMed ID: 22736773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of the MTOR and AKT1 genes polymorphisms on papillary thyroid cancer development.
    Maruei-Milan R; Saravani M; Heidari Z; Asadi-Tarani M; Salimi S
    IUBMB Life; 2020 Dec; 72(12):2601-2610. PubMed ID: 33107190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of interleukin-10 gene polymorphisms with severe generalized chronic periodontitis.
    Sumer AP; Kara N; Keles GC; Gunes S; Koprulu H; Bagci H
    J Periodontol; 2007 Mar; 78(3):493-7. PubMed ID: 17335372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The -137G/C Polymorphism in Interleukin-18 Gene Promoter Contributes to Chronic Lymphocytic and Chronic Myelogenous Leukemia Risk in Turkish Patients.
    Yalçın S; Mutlu P; Çetin T; Sarper M; Özgür G; Avcu F
    Turk J Haematol; 2015 Dec; 32(4):311-6. PubMed ID: 26376814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single nucleotide polymorphisms of ataxia telangiectasia mutated and the risk of papillary thyroid carcinoma.
    Song CM; Kwon TK; Park BL; Ji YB; Tae K
    Environ Mol Mutagen; 2015 Jan; 56(1):70-6. PubMed ID: 25196645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of
    Chatzikyriakidou A; Chorti A; Papavramidis T
    In Vivo; 2019; 33(6):2281-2285. PubMed ID: 31662568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-6, IL-10 and IL-17 gene polymorphisms in Iranian women with recurrent miscarriage.
    Bahadori M; Zarei S; Zarnani AH; Zarei O; Idali F; Hadavi R; Jeddi-Tehrani M
    Iran J Immunol; 2014 Jun; 11(2):97-104. PubMed ID: 24975966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The correlation between Kawasaki disease and polymorphisms of Tumor necrosis factor alpha and interleukin-10 gene promoter].
    Yang J; Li CR; Li YB; Li RX; Sun LB; Huang HJ; Wang GB
    Zhonghua Er Ke Za Zhi; 2003 Aug; 41(8):598-602. PubMed ID: 14744383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma.
    Akulevich NM; Saenko VA; Rogounovitch TI; Drozd VM; Lushnikov EF; Ivanov VK; Mitsutake N; Kominami R; Yamashita S
    Endocr Relat Cancer; 2009 Jun; 16(2):491-503. PubMed ID: 19286843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between a promoter polymorphism (rs2192752, -1028A/C) of interleukin 1 receptor, type I (IL1R1) and location of papillary thyroid carcinoma in a Korean population.
    Park SW; Kim MK; Kwon KH; Kim J
    Int J Immunogenet; 2012 Dec; 39(6):501-7. PubMed ID: 22594576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. hTERT gene polymorphism correlates with the risk and the prognosis of thyroid cancer.
    Gong L; Xu Y; Hu YQ; Ding QJ; Yi CH; Huang W; Zhou M
    Cancer Biomark; 2016 Jul; 17(2):195-204. PubMed ID: 27472887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PDGFRA promoter polymorphisms are associated with the risk of papillary thyroid cancer.
    Kim MJ; Kim SK; Park HJ; Chung DH; Park HK; Lee JS; Kwon KH; Chung JH
    Mol Med Rep; 2012 May; 5(5):1267-70. PubMed ID: 22327316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Association of genetic polymorphisms and haplotypes in hMLH1 and hMSH3 gene with the risk of papillary thyroid carcinoma].
    Shi WP; Bian JC; Jiang F; Ni HX; Zhu QX; Tang HW; Shen Q; Wu Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):390-5. PubMed ID: 18683134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GLP-1R polymorphism (rs1042044) and expression are associated with the risk of papillary thyroid cancer among the Egyptian population.
    Abdul-Maksoud RS; Elsayed WSH; Rashad NM; Elsayed RS; Elshorbagy S; Hamed MG
    Gene; 2022 Aug; 834():146597. PubMed ID: 35598685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphism of the NFKB1 affects the serum inflammatory levels of IL-6 in Hashimoto thyroiditis in a Turkish population.
    Koc A; Batar B; Celik O; Onaran I; Tasan E; Sultuybek GK
    Immunobiology; 2014 Jul; 219(7):531-6. PubMed ID: 24703107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.